NAC: Clinical Trials

19 trials of NAC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 4 unknown, 3 active not recruiting, 3 terminated. 19 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 319Completed 9, Unknown 4, Active not recruiting 3, Terminated 3
Phase 24Terminated 2, Active not recruiting 1, Completed 1

Follow NAC: new trials by email Literature Review of NAC trials Research Report on NAC

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients
N-acetyl cysteine, Metfomin - Polycystic Ovary Syndrome
Phase 3CompletedCairo University1022025-03-012026-10-21
Safety and Efficacy of N-Acetylcysteine Mouthwash in Prevention of Mucositis in HSCT Patients
N-Acetylcysteine 600mg/tab, Placebo - Oral Mucositis, Hematopoietic Stem Cell Transplantation (HSCT)
Phase 3Active not recruitingTehran University of Medical Sciences1062024-08-182026-01-08
NAC vs Placebo on Opioid Use for Hysterectomy
IV N-acetylcysteine, IV Placebo - Hysterectomy
Phase 3CompletedMedical University of South Carolina2402023-11-302026-10-09
The Use of N-acetylcysteine for Thrombotic Events After Allogenic Hematopoietic Stem Cell Transplantation
N-acetyl-cysteine, Busulfan, Cytarabine - Thrombotic Disorder
Phase 3UnknownThe First Affiliated Hospital of Soochow University2602023-08-012023-06-18
A Pan-TB Regimen Targeting Host and Microbe
Sutezolid, N-acetyl cysteine, Pretomanid - Tuberculosis
Phase 2 / Phase 3Active not recruitingThe Aurum Institute NPC3522023-07-282025-05-28
Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial
N-acetyl cysteine, Placebo - Idiopathic Pulmonary Fibrosis
Phase 3CompletedFernando J Martinez2022020-12-172026-03-20
Inflammatory Regulation Effect of NAC on COVID-19 Treatment
N-Acetyl cysteine, Placebo - COVID-19
Phase 3UnknownDr. Tariq Alhawassi11802020-08-012020-07-21
Correction of Neonatal Glutathione by N-acetylcysteine in Pregnant Women at Risk of Premature Birth (GSH MAP)
N-acetylcysteine, Placebo - Preterm Delivery
Phase 2 / Phase 3TerminatedNantes University Hospital392018-11-052022-12-19
Risk Stratification-directed NAC for Prevention of Poor Hematopoietic Reconstitution
N-acetyl-L-cysteine - Stem Cell Transplant Complications
Phase 3UnknownPeking University People's Hospital1302018-10-012021-09-14
A Safety and Efficacy Study of NAC in Patients With TA-TMA
N-Acetylcysteine, Placebo Oral Tablet - Thrombotic Microangiopathies, Hematologic Diseases
Phase 3CompletedThe First Affiliated Hospital of Soochow University1702017-11-012022-02-14
"Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients"
N-Acetylcysteine, Placebo, IPPI (Integrated Preventive Psychological Intervention) - Prodromal Schizophrenia
Phase 3TerminatedUniversity Hospital, Bonn482016-09-012022-05-09
N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis
N-acetyl cysteine (NAC) - Alcoholic Hepatitis, Infection
Phase 3UnknownImperial College London422015-10-012021-11-09
NAC Effect on Hox Genes Expressions in RIF
N-acetyl cysteine, Placebos - Female Infertility
Phase 3CompletedRoyan Institute402015-02-012019-03-05
Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment
N-Acetylcysteine, Placebo - Cannabis Dependence
Phase 3CompletedMedical University of South Carolina3022014-01-012018-05-24
Prevention of Serious Adverse Events Following Angiography
IV isotonic saline, IV isotonic bicarbonate, N-acetylcysteine - Acute Renal Failure, Kidney Disease
Phase 3CompletedVA Office of Research and Development51772013-10-072025-11-05
Use of N-Acetylcysteine (NAC) in Fingernail Biting
N-Acetylcysteine (NAC), Placebo - Onychophagia
Phase 3CompletedKevin Gray, MD232013-10-012018-10-03
Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention
NAC, Saline - Acute ST Segment Elevation Myocardial Infarction
Phase 3Active not recruitingSuleyman Demirel University1002013-01-012025-05-20
A Clinical Trial for CTD-ILD Treatment
N-Acetylcysteine - Interstitial Lung Disease, Connective Tissue Disease
Phase 2 / Phase 3TerminatedUniversity of Michigan52011-12-012017-04-06
Protective Effect of N-acetylcysteine Against From Ototoxicity
N-acetylcysteine - Hearing Loss, Extreme
Phase 2 / Phase 3CompletedTC Erciyes University602010-06-012011-11-16

Conditions studied

Acute Kidney Injury (1)  ·  Anxiety Disorders (1)  ·  Arthritis, Rheumatoid (1)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  COVID-19 (1)  ·  Connective Tissue Diseases (1)  ·  Coronary Artery Disease (1)  ·  Deafness (1)  ·  Depression (1)  ·  Dermatomyositis (1)  ·  Hematologic Diseases (1)  ·  Hepatitis, Alcoholic (1)  ·  Idiopathic Pulmonary Fibrosis (1)  ·  Infections (1)  ·  Infertility, Female (1)

Sponsors

Medical University of South Carolina (2)  ·  The First Affiliated Hospital of Soochow University (2)  ·  Cairo University (1)  ·  Dr. Tariq Alhawassi (1)  ·  Fernando J Martinez (1)  ·  Imperial College London (1)  ·  Kevin Gray, MD (1)  ·  Nantes University Hospital (1)  ·  Peking University People's Hospital (1)  ·  Royan Institute (1)  ·  Suleyman Demirel University (1)  ·  TC Erciyes University (1)  ·  Tehran University of Medical Sciences (1)  ·  The Aurum Institute NPC (1)  ·  University Hospital, Bonn (1)

Countries

United States (6)  ·  China (2)  ·  Turkey (Türkiye) (2)  ·  Australia (1)  ·  Egypt (1)  ·  France (1)  ·  Germany (1)  ·  Iran (1)  ·  Malaysia (1)  ·  Mozambique (1)  ·  New Zealand (1)  ·  South Africa (1)  ·  Tanzania (1)  ·  United Kingdom (1)

Top investigators

Kevin M Gray, MD (2)  ·  Amr Z Abdelhamid, PhD (1)  ·  Ashraf Moini, MD (1)  ·  Cathie Spino, ScD (1)  ·  Depei Wu, MD. PhD. (1)  ·  Eglal A Mostafa Bassiouny, PhD (1)  ·  Fernando J Martinez, MD (1)  ·  Imre Noth, MD (1)  ·  Ismail Kocyigit, MD (1)  ·  Kevin Flaherty, MS, MD (1)  ·  Mark Thursz, MD (1)  ·  Maryam Shahhoseini, PhD (1)  ·  Parvaneh Afsharian, PhD (1)  ·  Professor Robert Wallis, MD (1)

Results publications

PMID 25073872, PMID 26860769, PMID 28623823, PMID 28847455, PMID 29130810, PMID 31712969, PMID 34197135, PMID 35084903, PMID 35473809, PMID 36514019, PMID 41749341, PMID 42829889

NIH funding

U10DA013045 (1), U10DA013727 (1), U10DA013732 (1), U10DA015815 (1), U10DA015831 (1), U10DA020024 (1), U24HL145265 (1), UG1DA013727 (1)